Max Wohlauer
Concepts (392)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vascular Surgical Procedures | 18 | 2024 | 352 | 3.510 |
Why?
| | Endovascular Procedures | 9 | 2024 | 390 | 1.630 |
Why?
| | Thrombosis | 3 | 2025 | 398 | 1.400 |
Why?
| | Peripheral Arterial Disease | 5 | 2025 | 507 | 1.200 |
Why?
| | Ischemia | 7 | 2025 | 421 | 1.140 |
Why?
| | Blood Coagulation Disorders | 10 | 2016 | 190 | 1.110 |
Why?
| | Surgeons | 7 | 2024 | 351 | 1.100 |
Why?
| | Arterial Occlusive Diseases | 2 | 2025 | 88 | 1.030 |
Why?
| | Blood Vessel Prosthesis Implantation | 6 | 2022 | 219 | 1.010 |
Why?
| | Shock, Hemorrhagic | 10 | 2024 | 195 | 0.960 |
Why?
| | Thrombelastography | 13 | 2020 | 182 | 0.960 |
Why?
| | Vascular System Injuries | 3 | 2023 | 79 | 0.930 |
Why?
| | Ergonomics | 3 | 2026 | 30 | 0.930 |
Why?
| | Acute Lung Injury | 8 | 2015 | 312 | 0.920 |
Why?
| | Elective Surgical Procedures | 3 | 2024 | 216 | 0.870 |
Why?
| | Baseball | 1 | 2025 | 57 | 0.840 |
Why?
| | Aortic Aneurysm, Abdominal | 4 | 2022 | 164 | 0.840 |
Why?
| | Extremities | 1 | 2025 | 142 | 0.830 |
Why?
| | Brachial Artery | 1 | 2025 | 207 | 0.810 |
Why?
| | Leg Injuries | 1 | 2023 | 25 | 0.760 |
Why?
| | Wounds and Injuries | 13 | 2016 | 959 | 0.750 |
Why?
| | Intermittent Claudication | 2 | 2022 | 121 | 0.740 |
Why?
| | Diabetic Foot | 1 | 2022 | 25 | 0.740 |
Why?
| | Burnout, Professional | 4 | 2021 | 493 | 0.690 |
Why?
| | Blood Transfusion | 8 | 2016 | 394 | 0.650 |
Why?
| | Pneumonia, Viral | 3 | 2020 | 387 | 0.650 |
Why?
| | Coronavirus Infections | 3 | 2020 | 379 | 0.650 |
Why?
| | Sexism | 1 | 2021 | 70 | 0.640 |
Why?
| | Mental Health | 3 | 2022 | 779 | 0.630 |
Why?
| | Cultural Diversity | 1 | 2021 | 83 | 0.630 |
Why?
| | Proteomics | 4 | 2025 | 1203 | 0.620 |
Why?
| | Aortic Aneurysm, Thoracic | 3 | 2017 | 135 | 0.620 |
Why?
| | Musculoskeletal Pain | 1 | 2020 | 48 | 0.610 |
Why?
| | Aggression | 1 | 2021 | 171 | 0.610 |
Why?
| | Muscle Fatigue | 1 | 2020 | 98 | 0.590 |
Why?
| | Multiple Organ Failure | 4 | 2013 | 122 | 0.590 |
Why?
| | Foot | 1 | 2020 | 109 | 0.570 |
Why?
| | Racism | 1 | 2021 | 147 | 0.570 |
Why?
| | Pandemics | 8 | 2023 | 1707 | 0.570 |
Why?
| | Internship and Residency | 4 | 2020 | 1281 | 0.570 |
Why?
| | Continuity of Patient Care | 2 | 2012 | 298 | 0.570 |
Why?
| | Tendons | 1 | 2020 | 136 | 0.570 |
Why?
| | Betacoronavirus | 3 | 2020 | 288 | 0.560 |
Why?
| | Occupational Diseases | 1 | 2020 | 164 | 0.560 |
Why?
| | Axillary Artery | 2 | 2015 | 14 | 0.550 |
Why?
| | Lymph | 3 | 2015 | 31 | 0.540 |
Why?
| | Running | 1 | 2020 | 235 | 0.510 |
Why?
| | Serum Albumin, Human | 1 | 2017 | 7 | 0.510 |
Why?
| | Vascular Diseases | 1 | 2020 | 252 | 0.510 |
Why?
| | Hypoalbuminemia | 1 | 2017 | 26 | 0.500 |
Why?
| | Attitude of Health Personnel | 3 | 2024 | 1219 | 0.480 |
Why?
| | Research Design | 1 | 2022 | 1143 | 0.470 |
Why?
| | Curriculum | 3 | 2019 | 1079 | 0.460 |
Why?
| | Blood Platelet Disorders | 2 | 2013 | 10 | 0.460 |
Why?
| | Axilla | 1 | 2015 | 51 | 0.450 |
Why?
| | Humans | 69 | 2026 | 146342 | 0.440 |
Why?
| | Aneurysm, False | 1 | 2015 | 46 | 0.440 |
Why?
| | Treatment Outcome | 20 | 2025 | 11821 | 0.420 |
Why?
| | Fibrinolysis | 4 | 2025 | 162 | 0.420 |
Why?
| | Osteosarcoma | 1 | 2015 | 100 | 0.420 |
Why?
| | Soft Tissue Neoplasms | 1 | 2015 | 133 | 0.410 |
Why?
| | Diabetes Mellitus | 1 | 2022 | 1101 | 0.400 |
Why?
| | Male | 44 | 2025 | 73396 | 0.380 |
Why?
| | Matrix Metalloproteinase 13 | 1 | 2012 | 25 | 0.370 |
Why?
| | Bone Neoplasms | 1 | 2015 | 272 | 0.370 |
Why?
| | Physicians | 1 | 2021 | 955 | 0.360 |
Why?
| | Neutrophils | 4 | 2015 | 1133 | 0.360 |
Why?
| | Saline Solution, Hypertonic | 1 | 2012 | 43 | 0.360 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2021 | 1408 | 0.360 |
Why?
| | Common Bile Duct Neoplasms | 1 | 2012 | 28 | 0.360 |
Why?
| | Duodenal Neoplasms | 1 | 2012 | 26 | 0.360 |
Why?
| | Acute Disease | 6 | 2025 | 1038 | 0.360 |
Why?
| | Carcinoma, Papillary | 1 | 2013 | 83 | 0.360 |
Why?
| | Ampulla of Vater | 1 | 2012 | 40 | 0.360 |
Why?
| | Decompression, Surgical | 2 | 2025 | 115 | 0.360 |
Why?
| | Personnel Staffing and Scheduling | 1 | 2012 | 102 | 0.360 |
Why?
| | Pancreatic Ducts | 1 | 2013 | 81 | 0.350 |
Why?
| | Colonic Diseases | 1 | 2012 | 39 | 0.350 |
Why?
| | Patient Handoff | 1 | 2012 | 45 | 0.350 |
Why?
| | Neoplasms, Multiple Primary | 1 | 2012 | 57 | 0.350 |
Why?
| | Intestinal Volvulus | 1 | 2012 | 23 | 0.350 |
Why?
| | Workload | 4 | 2026 | 170 | 0.350 |
Why?
| | Blood Coagulation | 5 | 2021 | 267 | 0.350 |
Why?
| | Hemodilution | 1 | 2011 | 11 | 0.340 |
Why?
| | Wounds, Penetrating | 1 | 2012 | 71 | 0.330 |
Why?
| | Multiple Trauma | 1 | 2012 | 118 | 0.330 |
Why?
| | Patient Care Management | 1 | 2011 | 54 | 0.330 |
Why?
| | Female | 40 | 2025 | 79499 | 0.320 |
Why?
| | Rats, Sprague-Dawley | 9 | 2015 | 2537 | 0.310 |
Why?
| | Wounds, Nonpenetrating | 2 | 2015 | 305 | 0.300 |
Why?
| | General Surgery | 1 | 2012 | 217 | 0.300 |
Why?
| | Mesentery | 4 | 2015 | 44 | 0.300 |
Why?
| | Time-to-Treatment | 2 | 2024 | 257 | 0.300 |
Why?
| | Carcinoma, Pancreatic Ductal | 1 | 2013 | 297 | 0.290 |
Why?
| | Delivery of Health Care, Integrated | 2 | 2024 | 305 | 0.280 |
Why?
| | Patient Transfer | 1 | 2012 | 224 | 0.280 |
Why?
| | Resuscitation | 3 | 2024 | 314 | 0.280 |
Why?
| | Risk Assessment | 9 | 2021 | 3712 | 0.270 |
Why?
| | Platelet Aggregation Inhibitors | 5 | 2022 | 499 | 0.260 |
Why?
| | Adult | 27 | 2025 | 41087 | 0.250 |
Why?
| | Thrombophilia | 2 | 2021 | 89 | 0.250 |
Why?
| | Time Factors | 9 | 2025 | 7109 | 0.250 |
Why?
| | Risk Factors | 10 | 2025 | 10921 | 0.240 |
Why?
| | Computer Simulation | 1 | 2011 | 1014 | 0.240 |
Why?
| | Rats | 8 | 2014 | 5586 | 0.240 |
Why?
| | Personnel Turnover | 1 | 2026 | 40 | 0.230 |
Why?
| | Back Pain | 1 | 2026 | 58 | 0.230 |
Why?
| | Blood Platelets | 4 | 2014 | 382 | 0.230 |
Why?
| | Anticoagulants | 4 | 2021 | 746 | 0.230 |
Why?
| | Software | 1 | 2011 | 676 | 0.230 |
Why?
| | Median Arcuate Ligament Syndrome | 1 | 2025 | 7 | 0.230 |
Why?
| | Celiac Artery | 1 | 2025 | 19 | 0.230 |
Why?
| | Middle Aged | 23 | 2025 | 36619 | 0.220 |
Why?
| | Balloon Occlusion | 2 | 2024 | 39 | 0.220 |
Why?
| | Retrospective Studies | 10 | 2025 | 17438 | 0.220 |
Why?
| | Adenocarcinoma | 1 | 2012 | 927 | 0.220 |
Why?
| | Adaptation, Psychological | 2 | 2021 | 721 | 0.220 |
Why?
| | Diagnosis, Differential | 3 | 2015 | 1503 | 0.220 |
Why?
| | Aged | 12 | 2025 | 26432 | 0.220 |
Why?
| | Hospitals, Public | 1 | 2025 | 30 | 0.220 |
Why?
| | Prospective Studies | 9 | 2022 | 8123 | 0.210 |
Why?
| | Education, Medical, Graduate | 2 | 2021 | 568 | 0.210 |
Why?
| | Angiography | 2 | 2023 | 206 | 0.210 |
Why?
| | Thrombectomy | 1 | 2025 | 79 | 0.210 |
Why?
| | Lower Extremity | 3 | 2023 | 453 | 0.210 |
Why?
| | Health Surveys | 3 | 2021 | 511 | 0.210 |
Why?
| | Pancreatic Neoplasms | 1 | 2013 | 944 | 0.210 |
Why?
| | Varicose Veins | 1 | 2024 | 16 | 0.200 |
Why?
| | Nurses | 1 | 2026 | 171 | 0.200 |
Why?
| | Kidney | 1 | 2012 | 1498 | 0.200 |
Why?
| | Injury Severity Score | 7 | 2016 | 572 | 0.200 |
Why?
| | Venous Thromboembolism | 2 | 2021 | 332 | 0.200 |
Why?
| | Brain Injuries | 3 | 2014 | 499 | 0.200 |
Why?
| | Heparin, Low-Molecular-Weight | 2 | 2014 | 37 | 0.190 |
Why?
| | Occupational Health | 3 | 2021 | 212 | 0.190 |
Why?
| | Patient Care Team | 2 | 2024 | 701 | 0.190 |
Why?
| | Pain | 2 | 2026 | 790 | 0.190 |
Why?
| | Arachidonic Acid | 2 | 2014 | 101 | 0.190 |
Why?
| | Endarterectomy, Carotid | 1 | 2023 | 63 | 0.190 |
Why?
| | Physician-Patient Relations | 2 | 2021 | 597 | 0.180 |
Why?
| | Ischemic Attack, Transient | 1 | 2023 | 71 | 0.180 |
Why?
| | Hospital Mortality | 2 | 2021 | 1051 | 0.180 |
Why?
| | Surveys and Questionnaires | 9 | 2026 | 6073 | 0.180 |
Why?
| | Robotic Surgical Procedures | 1 | 2025 | 210 | 0.180 |
Why?
| | Specialties, Surgical | 2 | 2020 | 88 | 0.180 |
Why?
| | Blood Coagulation Tests | 2 | 2020 | 72 | 0.180 |
Why?
| | Iliac Aneurysm | 1 | 2022 | 17 | 0.180 |
Why?
| | Observational Studies as Topic | 1 | 2022 | 133 | 0.180 |
Why?
| | Carotid Stenosis | 1 | 2023 | 103 | 0.180 |
Why?
| | Prevalence | 3 | 2020 | 2861 | 0.170 |
Why?
| | Pulmonary Embolism | 1 | 2024 | 246 | 0.170 |
Why?
| | Peripheral Vascular Diseases | 1 | 2022 | 102 | 0.170 |
Why?
| | United States | 10 | 2024 | 16136 | 0.170 |
Why?
| | Arteriovenous Fistula | 1 | 2021 | 36 | 0.170 |
Why?
| | Aortic Rupture | 1 | 2021 | 28 | 0.170 |
Why?
| | Point-of-Care Systems | 3 | 2012 | 185 | 0.170 |
Why?
| | Iliac Vein | 1 | 2021 | 13 | 0.160 |
Why?
| | Aorta | 1 | 2024 | 440 | 0.160 |
Why?
| | Work Capacity Evaluation | 1 | 2020 | 10 | 0.160 |
Why?
| | Catheters | 1 | 2021 | 73 | 0.160 |
Why?
| | Culturally Competent Care | 1 | 2021 | 66 | 0.160 |
Why?
| | Vena Cava, Inferior | 1 | 2021 | 80 | 0.160 |
Why?
| | Tenotomy | 1 | 2020 | 22 | 0.160 |
Why?
| | Tendon Transfer | 1 | 2020 | 24 | 0.150 |
Why?
| | Physicians, Women | 1 | 2021 | 92 | 0.150 |
Why?
| | Iatrogenic Disease | 1 | 2020 | 74 | 0.150 |
Why?
| | International Cooperation | 1 | 2020 | 193 | 0.150 |
Why?
| | Catheterization, Peripheral | 1 | 2021 | 116 | 0.150 |
Why?
| | Posture | 1 | 2020 | 182 | 0.140 |
Why?
| | Partnership Practice | 1 | 2018 | 3 | 0.140 |
Why?
| | Thromboembolism | 1 | 2020 | 129 | 0.140 |
Why?
| | Societies, Medical | 2 | 2020 | 907 | 0.140 |
Why?
| | Insurance Benefits | 1 | 2018 | 12 | 0.140 |
Why?
| | Infection Control | 1 | 2020 | 174 | 0.140 |
Why?
| | Mentors | 1 | 2021 | 217 | 0.140 |
Why?
| | Venous Thrombosis | 1 | 2021 | 199 | 0.140 |
Why?
| | Catheterization, Central Venous | 1 | 2020 | 121 | 0.140 |
Why?
| | Physical Endurance | 1 | 2020 | 278 | 0.140 |
Why?
| | Health Services Needs and Demand | 1 | 2020 | 287 | 0.130 |
Why?
| | Medically Uninsured | 1 | 2018 | 134 | 0.130 |
Why?
| | Pain Measurement | 1 | 2020 | 573 | 0.130 |
Why?
| | Walking | 1 | 2022 | 546 | 0.130 |
Why?
| | Triage | 1 | 2020 | 243 | 0.130 |
Why?
| | Statistics, Nonparametric | 3 | 2014 | 426 | 0.120 |
Why?
| | Insurance Coverage | 1 | 2018 | 248 | 0.120 |
Why?
| | Nutrition Assessment | 1 | 2017 | 90 | 0.120 |
Why?
| | Purinergic P2Y Receptor Antagonists | 2 | 2014 | 71 | 0.120 |
Why?
| | Biomechanical Phenomena | 1 | 2020 | 874 | 0.120 |
Why?
| | Colorado | 6 | 2026 | 4595 | 0.120 |
Why?
| | Chronic Disease | 3 | 2024 | 1827 | 0.120 |
Why?
| | Registries | 2 | 2024 | 2400 | 0.120 |
Why?
| | Hemostatic Techniques | 1 | 2016 | 50 | 0.110 |
Why?
| | Insurance, Health | 1 | 2018 | 318 | 0.110 |
Why?
| | Motor Activity | 1 | 2020 | 704 | 0.110 |
Why?
| | Receptor, PAR-2 | 1 | 2015 | 7 | 0.110 |
Why?
| | Phosphopyruvate Hydratase | 1 | 2015 | 26 | 0.110 |
Why?
| | Exsanguination | 2 | 2012 | 18 | 0.110 |
Why?
| | Recovery of Function | 1 | 2020 | 725 | 0.110 |
Why?
| | Plasminogen | 1 | 2015 | 26 | 0.110 |
Why?
| | Practice Guidelines as Topic | 2 | 2021 | 1591 | 0.110 |
Why?
| | Sex Factors | 1 | 2021 | 2107 | 0.110 |
Why?
| | Practice Patterns, Physicians' | 2 | 2024 | 1408 | 0.110 |
Why?
| | Aged, 80 and over | 5 | 2025 | 8391 | 0.110 |
Why?
| | Geriatric Assessment | 1 | 2017 | 244 | 0.110 |
Why?
| | Myocardial Infarction | 1 | 2022 | 1215 | 0.110 |
Why?
| | Cohort Studies | 3 | 2022 | 6077 | 0.110 |
Why?
| | Postoperative Complications | 3 | 2025 | 3034 | 0.110 |
Why?
| | Systemic Inflammatory Response Syndrome | 1 | 2015 | 97 | 0.110 |
Why?
| | Microcirculation | 1 | 2015 | 142 | 0.110 |
Why?
| | Down-Regulation | 1 | 2017 | 614 | 0.110 |
Why?
| | Kaplan-Meier Estimate | 1 | 2017 | 970 | 0.100 |
Why?
| | Biomedical Research | 1 | 2021 | 729 | 0.100 |
Why?
| | Blood Vessel Prosthesis | 3 | 2022 | 133 | 0.100 |
Why?
| | Medicaid | 1 | 2018 | 477 | 0.100 |
Why?
| | Odds Ratio | 1 | 2017 | 1077 | 0.100 |
Why?
| | Thrombin | 2 | 2015 | 175 | 0.100 |
Why?
| | Stroke | 1 | 2023 | 1287 | 0.100 |
Why?
| | Animals | 10 | 2015 | 38106 | 0.100 |
Why?
| | Chi-Square Distribution | 2 | 2012 | 517 | 0.100 |
Why?
| | Frailty | 1 | 2017 | 208 | 0.100 |
Why?
| | Proportional Hazards Models | 1 | 2017 | 1331 | 0.100 |
Why?
| | Limb Salvage | 2 | 2025 | 74 | 0.100 |
Why?
| | Subclavian Artery | 1 | 2013 | 28 | 0.100 |
Why?
| | Carotid Artery, Common | 1 | 2013 | 31 | 0.090 |
Why?
| | Prosthesis Design | 3 | 2022 | 358 | 0.090 |
Why?
| | Bronchoalveolar Lavage Fluid | 2 | 2012 | 642 | 0.090 |
Why?
| | History, 17th Century | 1 | 2012 | 14 | 0.090 |
Why?
| | History, 18th Century | 1 | 2012 | 19 | 0.090 |
Why?
| | Fibrinogen | 1 | 2014 | 182 | 0.090 |
Why?
| | Brazil | 2 | 2025 | 179 | 0.090 |
Why?
| | Medicare | 1 | 2018 | 920 | 0.090 |
Why?
| | Comorbidity | 2 | 2021 | 1665 | 0.090 |
Why?
| | History, 19th Century | 1 | 2012 | 63 | 0.090 |
Why?
| | Nebulizers and Vaporizers | 1 | 2012 | 63 | 0.090 |
Why?
| | Sigmoid Diseases | 1 | 2012 | 14 | 0.090 |
Why?
| | Social Responsibility | 1 | 2012 | 52 | 0.090 |
Why?
| | Arachidonate 5-Lipoxygenase | 1 | 2012 | 36 | 0.090 |
Why?
| | Neutrophil Infiltration | 1 | 2012 | 107 | 0.090 |
Why?
| | Isoflurane | 1 | 2012 | 41 | 0.090 |
Why?
| | Biopsy, Needle | 1 | 2012 | 183 | 0.090 |
Why?
| | 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid | 1 | 2011 | 5 | 0.090 |
Why?
| | Muscle, Skeletal | 1 | 2022 | 1818 | 0.090 |
Why?
| | Blood Transfusion, Autologous | 1 | 2011 | 18 | 0.090 |
Why?
| | Anesthetics, Inhalation | 1 | 2012 | 52 | 0.090 |
Why?
| | Stress, Psychological | 1 | 2020 | 1171 | 0.090 |
Why?
| | Trauma Severity Indices | 1 | 2012 | 115 | 0.090 |
Why?
| | Hydroxyeicosatetraenoic Acids | 1 | 2011 | 35 | 0.090 |
Why?
| | Multivariate Analysis | 2 | 2013 | 1543 | 0.090 |
Why?
| | Social Values | 1 | 2012 | 40 | 0.090 |
Why?
| | Random Allocation | 1 | 2012 | 366 | 0.090 |
Why?
| | Narration | 1 | 2012 | 82 | 0.090 |
Why?
| | Efficiency, Organizational | 1 | 2012 | 144 | 0.090 |
Why?
| | Kidney Function Tests | 1 | 2012 | 156 | 0.080 |
Why?
| | Extravascular Lung Water | 1 | 2011 | 9 | 0.080 |
Why?
| | Colectomy | 1 | 2012 | 119 | 0.080 |
Why?
| | Disseminated Intravascular Coagulation | 1 | 2011 | 34 | 0.080 |
Why?
| | History, 20th Century | 1 | 2012 | 330 | 0.080 |
Why?
| | Survival Rate | 2 | 2016 | 2092 | 0.080 |
Why?
| | Renal Replacement Therapy | 1 | 2012 | 102 | 0.080 |
Why?
| | Administration, Inhalation | 1 | 2012 | 567 | 0.080 |
Why?
| | Docosahexaenoic Acids | 1 | 2011 | 91 | 0.080 |
Why?
| | Abdominal Pain | 1 | 2012 | 149 | 0.080 |
Why?
| | Abdominal Injuries | 1 | 2012 | 122 | 0.080 |
Why?
| | Depression | 1 | 2020 | 1575 | 0.080 |
Why?
| | Oxidative Stress | 3 | 2014 | 1369 | 0.080 |
Why?
| | Health Care Surveys | 2 | 2024 | 541 | 0.080 |
Why?
| | Efficiency | 1 | 2011 | 102 | 0.080 |
Why?
| | Hypothermia | 1 | 2011 | 53 | 0.080 |
Why?
| | Quality Assurance, Health Care | 1 | 2012 | 349 | 0.080 |
Why?
| | Superoxides | 1 | 2011 | 198 | 0.080 |
Why?
| | Aorta, Thoracic | 1 | 2013 | 284 | 0.080 |
Why?
| | Adolescent | 6 | 2025 | 22557 | 0.080 |
Why?
| | Trauma Centers | 4 | 2016 | 441 | 0.080 |
Why?
| | Interprofessional Relations | 1 | 2012 | 275 | 0.080 |
Why?
| | Acidosis | 1 | 2011 | 105 | 0.080 |
Why?
| | Biomarkers | 3 | 2017 | 4340 | 0.080 |
Why?
| | Proteome | 1 | 2014 | 520 | 0.080 |
Why?
| | Pancreatectomy | 1 | 2013 | 289 | 0.080 |
Why?
| | Logistic Models | 2 | 2012 | 2126 | 0.070 |
Why?
| | Models, Animal | 1 | 2011 | 387 | 0.070 |
Why?
| | Safety | 1 | 2011 | 347 | 0.070 |
Why?
| | Endothelial Cells | 1 | 2015 | 876 | 0.070 |
Why?
| | Recurrence | 1 | 2012 | 1133 | 0.070 |
Why?
| | Cross-Sectional Studies | 4 | 2020 | 5899 | 0.070 |
Why?
| | Quality Improvement | 2 | 2021 | 1354 | 0.070 |
Why?
| | Immunohistochemistry | 1 | 2012 | 1712 | 0.070 |
Why?
| | Reperfusion Injury | 1 | 2011 | 300 | 0.070 |
Why?
| | Lymph Nodes | 1 | 2011 | 511 | 0.070 |
Why?
| | Tissue and Organ Procurement | 1 | 2012 | 305 | 0.070 |
Why?
| | Disease Models, Animal | 3 | 2014 | 4580 | 0.060 |
Why?
| | Sensitivity and Specificity | 1 | 2012 | 1998 | 0.060 |
Why?
| | Evidence-Based Medicine | 1 | 2011 | 731 | 0.060 |
Why?
| | Lung | 3 | 2015 | 4122 | 0.060 |
Why?
| | Chromatography, Liquid | 3 | 2014 | 453 | 0.060 |
Why?
| | Prognosis | 2 | 2013 | 4351 | 0.060 |
Why?
| | Communication | 1 | 2012 | 980 | 0.060 |
Why?
| | Embolectomy | 1 | 2025 | 13 | 0.050 |
Why?
| | Tandem Mass Spectrometry | 3 | 2014 | 576 | 0.050 |
Why?
| | Incidence | 1 | 2012 | 2936 | 0.050 |
Why?
| | Operative Time | 1 | 2025 | 195 | 0.050 |
Why?
| | Young Adult | 6 | 2025 | 14330 | 0.050 |
Why?
| | Databases, Factual | 2 | 2021 | 1493 | 0.050 |
Why?
| | Platelet Function Tests | 2 | 2014 | 37 | 0.050 |
Why?
| | Electronic Health Records | 1 | 2012 | 1210 | 0.050 |
Why?
| | Clinical Competence | 1 | 2012 | 1272 | 0.050 |
Why?
| | Aortography | 2 | 2013 | 54 | 0.050 |
Why?
| | Interdisciplinary Communication | 1 | 2024 | 200 | 0.050 |
Why?
| | Reproducibility of Results | 1 | 2011 | 3416 | 0.050 |
Why?
| | Receptors, Purinergic P2 | 2 | 2013 | 23 | 0.050 |
Why?
| | Platelet Activation | 2 | 2014 | 99 | 0.050 |
Why?
| | Mesenteric Artery, Inferior | 1 | 2022 | 1 | 0.050 |
Why?
| | Carotid Arteries | 1 | 2023 | 206 | 0.040 |
Why?
| | Iliac Artery | 1 | 2022 | 53 | 0.040 |
Why?
| | Off-Label Use | 1 | 2022 | 50 | 0.040 |
Why?
| | Product Labeling | 1 | 2021 | 12 | 0.040 |
Why?
| | Mitochondrial Proteins | 2 | 2015 | 263 | 0.040 |
Why?
| | Cooperative Behavior | 1 | 2024 | 471 | 0.040 |
Why?
| | Phlebography | 1 | 2021 | 38 | 0.040 |
Why?
| | Depersonalization | 1 | 2020 | 8 | 0.040 |
Why?
| | Blood Component Transfusion | 2 | 2012 | 99 | 0.040 |
Why?
| | Protective Factors | 1 | 2021 | 97 | 0.040 |
Why?
| | Tomography, X-Ray Computed | 3 | 2018 | 2786 | 0.040 |
Why?
| | Work-Life Balance | 1 | 2020 | 22 | 0.040 |
Why?
| | Fibrin Clot Lysis Time | 1 | 2020 | 10 | 0.040 |
Why?
| | Rivaroxaban | 1 | 2022 | 270 | 0.040 |
Why?
| | Partial Thromboplastin Time | 1 | 2020 | 53 | 0.040 |
Why?
| | Personal Protective Equipment | 1 | 2020 | 59 | 0.040 |
Why?
| | Heparin | 1 | 2021 | 247 | 0.040 |
Why?
| | Fibrin Fibrinogen Degradation Products | 1 | 2020 | 92 | 0.040 |
Why?
| | Aspirin | 1 | 2022 | 405 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2014 | 2022 | 0.040 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2020 | 522 | 0.030 |
Why?
| | Popliteal Artery | 1 | 2018 | 60 | 0.030 |
Why?
| | Patient Protection and Affordable Care Act | 1 | 2018 | 105 | 0.030 |
Why?
| | Stents | 1 | 2022 | 554 | 0.030 |
Why?
| | Clinical Decision-Making | 1 | 2021 | 365 | 0.030 |
Why?
| | Hemorrhage | 1 | 2022 | 825 | 0.030 |
Why?
| | Global Health | 1 | 2020 | 403 | 0.030 |
Why?
| | Host-Pathogen Interactions | 1 | 2020 | 366 | 0.030 |
Why?
| | Career Choice | 1 | 2019 | 237 | 0.030 |
Why?
| | Pilot Projects | 1 | 2022 | 1888 | 0.030 |
Why?
| | Guideline Adherence | 1 | 2021 | 594 | 0.030 |
Why?
| | Military Personnel | 1 | 2024 | 726 | 0.030 |
Why?
| | Renal Dialysis | 1 | 2020 | 461 | 0.030 |
Why?
| | Clinical Trials as Topic | 1 | 2021 | 1064 | 0.030 |
Why?
| | Alarmins | 1 | 2015 | 27 | 0.030 |
Why?
| | Emotions | 1 | 2020 | 559 | 0.030 |
Why?
| | Bacterial Translocation | 1 | 2015 | 51 | 0.030 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2015 | 132 | 0.030 |
Why?
| | Case-Control Studies | 2 | 2014 | 3647 | 0.030 |
Why?
| | Tranexamic Acid | 1 | 2015 | 63 | 0.030 |
Why?
| | Intensive Care Units | 1 | 2020 | 925 | 0.020 |
Why?
| | Mesenteric Artery, Superior | 1 | 2013 | 28 | 0.020 |
Why?
| | Renal Artery | 1 | 2013 | 42 | 0.020 |
Why?
| | Extracellular Matrix Proteins | 1 | 2014 | 156 | 0.020 |
Why?
| | Inflammation | 2 | 2015 | 2919 | 0.020 |
Why?
| | Cluster Analysis | 1 | 2014 | 496 | 0.020 |
Why?
| | Glasgow Coma Scale | 1 | 2014 | 211 | 0.020 |
Why?
| | Age Factors | 1 | 2020 | 3347 | 0.020 |
Why?
| | Platelet Count | 1 | 2013 | 95 | 0.020 |
Why?
| | Blood Proteins | 1 | 2014 | 239 | 0.020 |
Why?
| | Receptors, Purinergic P2Y12 | 1 | 2012 | 6 | 0.020 |
Why?
| | Leukotriene C4 | 1 | 2012 | 6 | 0.020 |
Why?
| | Chlorobenzenes | 1 | 2012 | 18 | 0.020 |
Why?
| | Reference Values | 1 | 2014 | 796 | 0.020 |
Why?
| | Leukotriene B4 | 1 | 2012 | 37 | 0.020 |
Why?
| | Anastomosis, Surgical | 1 | 2013 | 164 | 0.020 |
Why?
| | Lipoxygenase Inhibitors | 1 | 2012 | 34 | 0.020 |
Why?
| | Ticlopidine | 1 | 2012 | 52 | 0.020 |
Why?
| | Eicosanoids | 1 | 2012 | 58 | 0.020 |
Why?
| | Peroxidase | 1 | 2012 | 168 | 0.020 |
Why?
| | Cell Membrane | 1 | 2015 | 701 | 0.020 |
Why?
| | Dinoprostone | 1 | 2012 | 179 | 0.020 |
Why?
| | Fluorescent Antibody Technique | 1 | 2012 | 345 | 0.020 |
Why?
| | Mass Spectrometry | 1 | 2014 | 729 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2015 | 1163 | 0.020 |
Why?
| | Acute-Phase Proteins | 1 | 2011 | 66 | 0.020 |
Why?
| | Oxidation-Reduction | 1 | 2014 | 1075 | 0.020 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2011 | 326 | 0.020 |
Why?
| | Cerebrovascular Circulation | 1 | 2013 | 293 | 0.020 |
Why?
| | Health Services Accessibility | 1 | 2018 | 1107 | 0.020 |
Why?
| | Waiting Lists | 1 | 2012 | 251 | 0.020 |
Why?
| | Quality of Life | 1 | 2022 | 3200 | 0.020 |
Why?
| | Hemolysis | 1 | 2011 | 242 | 0.020 |
Why?
| | Membrane Glycoproteins | 1 | 2011 | 495 | 0.020 |
Why?
| | Indoles | 1 | 2012 | 511 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2012 | 2134 | 0.020 |
Why?
| | Carrier Proteins | 1 | 2011 | 728 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2011 | 4118 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2013 | 5439 | 0.010 |
Why?
| | Mice, Inbred C57BL | 1 | 2012 | 6034 | 0.010 |
Why?
| | Mice | 1 | 2012 | 18297 | 0.010 |
Why?
|
|
Wohlauer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|